Clinical Trial

Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts

Name: Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts — clinical trial record (NCT07307131)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This study compares the effectiveness and safety of two different intralesional treatments for cutaneous warts: a combination of furosemide and digoxin versus polidocanol.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-14.

Trial Details

NCT Number	NCT07307131
Lead Sponsor	Benha University
Conditions	Cutaneous Warts, Human Papilloma Virus (HPV)
Enrollment	64 participants
Start Date	2024-09-01
Primary Completion	2025-03-01 (estimated)
Study Completion	2025-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-02